Verified· 2 sources

J. Lamarck AG

Summary

About the company

J. Lamarck AG is an asset management and advisory firm focused on investments in the healthcare sector, notably biotechnology and pharmaceuticals. It offers investment products and services to private and institutional clients, including UCITS funds (Selectra Investment SICAV – J. Lamarck Biotech and J. Lamarck Pharma) and thematic products such as the J. Lamarck Swiss Healthcare Index.

AI-generated

Offering

Products & services

Industry:Holding Companies

✓ Offered4

Discretionary wealth management

Customised portfolios managed independently, with profile and needs analysis, a dynamic approach, and protection and growth of capital.

Advisory

Qualified, independent advice for those who keep direct control over their investment choices, with support for building and repositioning the portfolio.

Investment funds

UCITS funds and investment solutions in the healthcare sector, focusing on biotechnology, pharmaceuticals and healthcare innovations.

Thematic healthcare investment solutions

Investment solutions focused on biotechnology, pharmaceutical products and healthcare innovations, with selection based on scientific, clinical and regulatory analysis.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

J. Lamarck AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

J. Lamarck AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

J. Lamarck AG in comparison

Industry comparisons are coming soon

Similar companies